Navigation Links
33rd ESMO Congress in Stockholm, 12-16 September 2008
Date:9/5/2008

er

(Embargoed until Sunday, 14 September 2008, 15:30 CEST)

For patients with early stage breast cancer that has spread to the lymph nodes, adding docetaxel into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show. This advantage comes at the cost of an increased, but manageable, toxicity, Italian researchers report.

Pegylated liposomal doxorubicin beneficial in metastatic breast cancer

(Embargoed until Monday 15 September 2008, 12:30 CEST)

For women with metastatic breast cancer, treatment with an encapsulated form of the drug doxorubicin offers a well-tolerated option for maintenance therapy that delays progression and offers benefits in terms of survival, new results show presented by Spanish researcher Emilio Alba.

Gastrointestinal cancer

Late breaking data: New drug substantially extends survival in pancreatic

cancer

(Embargoed until Tuesday, 16 September 2008, 10:00 CEST)

A new form of chemotherapy that destroys new blood vessels that grow around tumours has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, Prof. Matthias Lohr from the Karolinska Institute reports.

Late breaking data: Gene marker indicates doubling of survival time in

advanced colorectal cancer treated with cetuximab

(Embargoed until Tuesday, 16 September 2008, 08:30 CEST)

Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, show results presented by Dr. Christos Karapetis from Flinders University in Australia.

Ovarian Cancer

Drug shows promise in ovarian cancer

(Embargoed until Monday, 15 September 2008, 10:45 CEST)

An investigational drug that combats ovarian cancer b
'/>"/>

SOURCE ESMO European Society for Medical Oncology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
4. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Bruker Announces Availability of New HUPO World Congress Proteomics Posters on Web Site
9. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. The Library of Congress in your wrist watch?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Armetheon, Inc. ( ... novel mid- to late-stage cardiovascular drug candidates, today ... its first round of financing. The Series A ... Hercules Bioventures with participation from investors that included ... executive, Dr. Larry Hsu , the founder ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
(Date:8/28/2014)... 28, 2014 Supplementing their complete ... promotion for Eppendorf Safe Lock Centrifuge Tubes ... the highest quality tubes at an affordable price. ... customers doing chemical, medical, pharmaceutical, and life science ... not regularly able to afford Eppendorf products. , ...
(Date:8/27/2014)... 27, 2014 Green & Grow Inc. ... B funding and secured Otter Capital as a significant ... accelerate commercialization of GGI’s Agriplier™ technology, building on recent ... , “Since our first meeting, we have been impressed ... product space,” said Alan Sobba, President and CEO of ...
Breaking Biology Technology:Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3
... with researchers from Grenoble and Tokyo, have succeeded in taking ... They were able to define two little quantum dots (QDs), ... single electron from one of them using a sound wave, ... single electron "surfs" thus from one quantum dot to the ...
... Parent Project Muscular Dystrophy (PPMD) , the ... a cure for Duchenne muscular dystrophy (Duchenne) , announced ... of Physiology at the University of Pennsylvania and Pennsylvania Muscle ... (Logo: http://photos.prnewswire.com/prnh/20100119/DC39975LOGO ) Dr. Khurana is ...
... Inc., a privately-held global diagnostics company for human and ... president and CEO, will be presenting at AdvaMed 2011: ... 2011 at 11:00 a.m. in room 204A of the ... The presentation will include an overview of ...
Cached Biology Technology:Like fish on waves: electrons go surfing 2Like fish on waves: electrons go surfing 3Parent Project Muscular Dystrophy Awards End Duchenne Grant to University of Pennsylvania's Dr. Tejvir S. Khurana 2Parent Project Muscular Dystrophy Awards End Duchenne Grant to University of Pennsylvania's Dr. Tejvir S. Khurana 3SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C. 2
(Date:8/28/2014)... Access to Research Careers) Program has announced the ... America,s 27th Annual Mouse Molecular Genetics Conference from ... Grove, California. These awards are meant to ... scientists from underrepresented groups into the mainstream of ... participation of young scientists at the Genetics Society ...
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has ... College of Sports Medicine,s Conference on Integrative Physiology ... Florida. These awards are meant to promote ... from underrepresented groups into the mainstream of the ... of young scientists at the American College of ...
(Date:8/28/2014)... release is available in German . ... are now built with the help of sophisticated assembly lines. ... are an important part of these assembly lines. In the ... in various work stages arranged in a precise spatial and ... of the line. , The creation of such an assembly ...
Breaking Biology News(10 mins):Nanoscale assembly line 2Nanoscale assembly line 3
... More than six percent of expectant mothers in Quebec consume ... fetuses, according to a Universit de Montral investigation published in ... these women will voluntarily terminate their pregnancy fearing congenital malformations, ... percent higher than in the rest of the population. ...
... , REDWOOD CITY, Calif., Nov. 17 ... and authentication solutions, today announced that its customer, ... in security and privacy protection for its Picis ... incorporates DigitalPersona,s U.are.U® Fingerprint Readers and One Touch® ...
... Centre in Norwich, UK, have shown how plants can protect ... growing tips of plant roots and shoots have an in-built ... the cell to ,commit suicide, rather than pass on its ... roots and shoots, small populations of stem cells, through which ...
Cached Biology News:Some prescription meds can harm fetus 2Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 2Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 3Protecting the future: How plant stem cells guard against genetic damage 2
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
Request Info...
Request Info...
... Nebulizers are available in two product models - ... two models is that the 6000AT+ includes a ... drier aerosol for improved detection limits and reduced ... a range of elements by 10-40 times. Note ...
Biology Products: